Cargando…
Multiple Myeloma and Bisphosphonate-Related Osteonecrosis of the Mandible Associated with Dental Implants
Multiple myeloma (MM) is a malignant plasma cell disorder and more than 30% of patients with this pathology develop osteolytic lesions in the jaw. Either pamidronate or zoledronic acid is recommended in patients with MM who have one or more lytic lesions. However, bisphosphonate-related osteonecrosi...
Autores principales: | Junquera, Luis, Gallego, Lorena, Pelaz, Alejandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335612/ https://www.ncbi.nlm.nih.gov/pubmed/22567443 http://dx.doi.org/10.1155/2011/568246 |
Ejemplares similares
-
The use of pedicled buccal fat pad combined with sequestrectomy
in bisphosphonate-related osteonecrosis of the maxilla
por: Gallego, Lorena, et al.
Publicado: (2012) -
Alternative treatments for oral bisphosphonate-related osteonecrosis of the jaws: A pilot study comparing fibrin rich in growth factors and teriparatide
por: Pelaz, Alejandro, et al.
Publicado: (2014) -
Bisphosphonate-related osteonecrosis of the jaw and dental implants
por: Qamheya, Ala Hassan A., et al.
Publicado: (2016) -
Conservative Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma Patients
por: Melea, Pelagia I., et al.
Publicado: (2014) -
Current Controversies in Classification, Management, and Prevention of Bisphosphonate-Related Osteonecrosis of the Jaw
por: Ascani, Giuliano, et al.
Publicado: (2014)